Ecovyst, Inc. (ECVT)
12.75
-0.04
(-0.31%)
USD |
NYSE |
Jun 10, 16:00
12.72
-0.03
(-0.24%)
Pre-Market: 20:00
Ecovyst Total Liabilities (Quarterly) : 671.43M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 671.43M |
| December 31, 2025 | 657.54M |
| September 30, 2025 | 1.127B |
| June 30, 2025 | 1.104B |
| March 31, 2025 | 1.088B |
| December 31, 2024 | 1.102B |
| September 30, 2024 | 1.111B |
| June 30, 2024 | 1.103B |
| March 31, 2024 | 1.119B |
| December 31, 2023 | 1.132B |
| September 30, 2023 | 1.135B |
| June 30, 2023 | 1.146B |
| March 31, 2023 | 1.156B |
| December 31, 2022 | 1.177B |
| September 30, 2022 | 1.192B |
| June 30, 2022 | 1.190B |
| March 31, 2022 | 1.170B |
| December 31, 2021 | 1.190B |
| September 30, 2021 | 1.196B |
| Date | Value |
|---|---|
| June 30, 2021 | 1.883B |
| March 31, 2021 | 1.877B |
| December 31, 2020 | 1.921B |
| September 30, 2020 | 2.520B |
| June 30, 2020 | 2.471B |
| March 31, 2020 | 2.556B |
| December 31, 2019 | 2.536B |
| September 30, 2019 | 2.629B |
| June 30, 2019 | 2.722B |
| March 31, 2019 | 2.707B |
| December 31, 2018 | 2.663B |
| September 30, 2018 | 2.694B |
| June 30, 2018 | 2.775B |
| March 31, 2018 | 2.816B |
| December 31, 2017 | 2.784B |
| September 30, 2017 | 3.335B |
| June 30, 2017 | 3.326B |
| March 31, 2017 | 3.234B |
| December 31, 2016 | 3.427B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Olin Corp. | 5.619B |
| Stepan Co. | 1.140B |
| Ascent Industries Co. | 20.97M |
| Solesence, Inc. | 30.83M |
| BioLargo, Inc. | 8.752M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.247B |
| Shareholders Equity (Quarterly) | 575.18M |
| Debt to Equity Ratio | 0.7582 |
| Current Ratio | 2.379 |
| Net Debt Paydown Yield | 6.50% |